NCT03239951View on ClinicalTrials.gov

Study to Assess the Efficacy, Safety and Tolerability of (iTind)

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

January 20, 2020

Study Completion Date

March 31, 2020

Conditions
BPH
Interventions
DEVICE

iTind

temporary implant

Trial Locations (3)

Unknown

Firmly Park Hospital, Frimley

Norwich University Hospital, Norwich

SE1 9RT

King's college, London

Sponsors

Lead Sponsor

Medi-Tate Ltd.
All Listed Sponsors
lead

Medi-Tate Ltd.

INDUSTRY

NCT03239951 - Study to Assess the Efficacy, Safety and Tolerability of (iTind) | Biotech Hunter | Biotech Hunter